CAS: 35542-01-9 - 5-Methoxyuridine
Formula:C10H14N2O7
InChI:InChI=1S/C10H14N2O7/c1-18-4-2-12(10(17)11-8(4)16)9-7(15)6(14)5(3-13)19-9/h2,5-7,9,13-15H,3H2,1H3,(H,11,16,17)/t5-,6-,7-,9-/m1/s1
InChI key:InChIKey=ZXIATBNUWJBBGT-JXOAFFINSA-N
SMILES:O=C1NC(=O)N(C=C1OC)C2OC(CO)C(O)C2O
- Synonyms:
- Uridine, 5-methoxy-
- 5-Methoxyuridine
5-METHOXYURIDINE
CAS:35542-01-9
Formula:
C10H14N2O7
Purity:
95%
Color and Shape:
Solid
Molecular weight:
274.2274
Ref: IN-DA00C0PY
1g | 86.00 € | ||
5g | 242.00 € | ||
100mg | 26.00 € | ||
250mg | 42.00 € |
Estimated delivery in United States, on Wednesday 8 Jan 2025
5-Methoxyuridine
CAS:35542-01-9
Formula:
C10H14N2O7
Purity:
(HPLC) ≥ 98.0%
Color and Shape:
White to off-white powder
Molecular weight:
274.23
Ref: 7W-GN1335
Undefined size | To inquire |
Estimated delivery in United States, on Thursday 9 Jan 2025
5-Methoxyuridine
CAS:35542-01-9
5-Methoxyuridine (Mo5U) is an antitumor purine analog that inhibits DNA synthesis and induces apoptosis in …
Formula:
C10H14N2O7
Purity:
99.43%
Color and Shape:
Liquid
Molecular weight:
274.23
Ref: TM-TNU0123
100mg | 41.00 € | ||
500mg | 84.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methoxypyrimidine-2,4(1H,3H)-dione
CAS:35542-01-9
Purity:
95.0%
Molecular weight:
274.22900390625
Ref: 10-F464612
5g | 252.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
5-Methoxyuridine
CAS:35542-01-9
5-Methoxyuridine is a nucleoside that is structurally related to uridine. It is an intermediate in …
Formula:
C10H14N2O7
Purity:
Min. 98 Area-%
Color and Shape:
Powder
Molecular weight:
274.23 g/mol
Ref: 3D-NM08028
10mg | 182.00 € | ||
25mg | 322.00 € | ||
50mg | 495.00 € | ||
100mg | 670.00 € | ||
250mg | 1,053.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
5-Methoxyuridine
Controlled ProductCAS:35542-01-9
Formula:
C10H14N2O7
Color and Shape:
Neat
Molecular weight:
274.23
Ref: TR-M271740
500mg | 2,143.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025